A coordinated management strategy that integrates primary care, specialist collaboration, and patient advocacy ensures holistic care for dermatomyositis patients. Regular monitoring, personalized ...

The following is a summary of “Validity of diagnosis codes to identify a dermatomyositis cohort from electronic health records,” published in the January 2025 issue of Dermatology by Silberzweig et al ...

Pharmacologic therapies are the cornerstone of dermatomyositis management, aimed at reducing inflammation, suppressing autoimmunity, and preventing disease progression. Treatment strategies are ...

Treatment with dazukibart, a monoclonal antibody targeting interferon beta, yielded a rapid reduction in dermatomyositis disease activity in adults with skin-predominant and muscle-predominant ...